We only have this paper's title and publication details.
Read it at the sourceObservational analysis reveals improved efficacy of HDAC inhibitors with immunotherapy in solid tumors, suggesting vascular normalization may reduce toxicity.
The toxicity of Combined HDAC inhibitor with anti-angiogenesis therapy
No takes yet. Share an insight, caveat, or question.
Wang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: